Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lemborexant morning driving performance crossover study in healthy adults and elderly volunteers
NL-OMON44071Active, not recruiting
- Sponsor
- Eisai Co., Ltd.
- Start
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of lemborexant in Insomnia (5 arms), sponsored by Eisai Co., Ltd. Primary endpoint: Standard deviation of lateral position. Started Nov 2015; status: active, not recruiting.
02
Drugs
lemborexant
03
Conditions
Insomnia
Beyond the preview
Go deeper on NL-OMON44071.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON44071.